Labour government

Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

Retrieved on: 
Tuesday, February 7, 2023
Marketing, RTF, Food, Food and Drug Administration, CNS, The Legal 500, Advertising, Cancer, Bias, Court, Therapy, Survival, Advisory Committee, Labour government, Patient, FDA, District court, Investment, Aerospace, Letter, News, Medical device, Pharmaceutical industry, Security (finance)

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • Y-mAbs is a clinical-stage biopharmaceutical company focused on developing antibody therapeutics and medicines for the treatment of cancer patients of all ages.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

AVAYA HOLDINGS CORP. (NYSE: AVYA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Avaya Holdings Corp. (NYSE: AVYA)

Retrieved on: 
Tuesday, February 7, 2023
COSO, Communication, Software, NYSE, The Legal 500, Advertising, Court, News, Kleffman v. Vonage Holdings Corp., EBITDA, Audit committee, Labour government, District court, Report, Investment, Ethics, Form, Committee, AVYA, Committee of Sponsoring Organizations of the Treadway Commission, Annual report, Security (finance), Property management, Renewable energy, Avaya

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Avaya Holdings Corp. (“Avaya” or the “Company”) (NYSE: AVYA) between November 22, 2021 and November 29, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Middle District of North Carolina and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Middle District of North Carolina and alleges violations of the Securities Exchange Act of 1934.
  • If you purchased or acquired Avaya securities, and/or would like to discuss your legal rights and options please visit Avaya Holdings Corp.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NATIONAL VISION HOLDINGS, INC. (NASDAQ: EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against National Vision Holdings, Inc. (NASDAQ: EYE)

Retrieved on: 
Tuesday, February 7, 2023
CSS, Lens (anatomy), Optometry, COVID-19, The Legal 500, EPS, Advertising, Court, Labour government, District court, Investment, Qatar National Vision 2030, Glasses, EYE, News, Security (finance)

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of National Vision Holdings, Inc. (“National Vision” or the “Company”) (NASDAQ: EYE) between May 13, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Georgia and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SOTERA HEALTH COMPANY (NASDAQ: SHC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sotera Health Company (NASDAQ: SHC)

Retrieved on: 
Tuesday, February 7, 2023
GTCR, Health, Safety, Culture, Goldman Sachs, JPMorgan Chase, Ethylene oxide, The Legal 500, Advertising, Offerings, Cancer, Atmosphere, Risk, Court, EPA, Sterilization, SPO, Class, Labour government, IPO, NATA, Warburg Pincus, District court, Probability, Investment, Pressure, News, Tobacco, Security (finance), Oil, Sotera Tschetter, Nordion

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired Sotera Health Company (“Sotera” or the “Company”) common stock: (i) pursuant and/or traceable to the Company’s initial public offering conducted on or around November 20, 2020 (the “IPO”); (ii) pursuant and/or traceable to the Company’s secondary public offering conducted on or around March 18, 2021 (the “SPO,” and together with the IPO, the “Offerings”); and/or (iii) between November 20, 2020 and September 19, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Ohio and alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Sotera Health Company Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • The Company’s sterilization services rely on three primary technologies, one of which is Ethylene Oxide (“EtO”) processing.
  • Sotera, through its Sterigenics business, conducts or has conducted EtO processing at facilities located in Illinois, California, Georgia, and New Mexico.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ALLIANZ SE (OTC: ALIZY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allianz SE (OTC: ALIZY)

Retrieved on: 
Tuesday, February 7, 2023
Annual report, Allianz Global Investors, Security (finance), The Legal 500, Advertising, Central District, Risk, Court, OTC, News, Labour government, SE, District court, AGI, Investment, Renewable energy, Allianz

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Allianz SE (“Allianz” or the “Company”) (OTC: ALIZY) between March 9, 2018 and May 17, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Allianz SE Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877) 779-1414 or [email protected] to discuss your rights.
  • Allianz, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide.
  • Allianz Global Investors U.S. LLC (“AGI US”) is a subsidiary of Allianz.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Epiq Service Cloud Honored as National Law Journal Legal Technology Trailblazer

Retrieved on: 
Monday, February 6, 2023
Cloud, Spend, Automation, Discovery, NLJ, Risk, Intelligence, Labour government, Artificial intelligence, Workflow, Cryptocurrency, Audit

NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Epiq, a global technology-enabled leader to the legal industry and corporations, is pleased to announce that its comprehensive and integrated suite of legal productivity and intelligence solutions, Epiq Service Cloud , has been named to the National Law Journal’s list of Legal Technology Trailblazers .

Key Points: 
  • NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Epiq, a global technology-enabled leader to the legal industry and corporations, is pleased to announce that its comprehensive and integrated suite of legal productivity and intelligence solutions, Epiq Service Cloud , has been named to the National Law Journal’s list of Legal Technology Trailblazers .
  • The NLJ Legal Technology Trailblazers designation, now in its third year, recognizes products and companies that are innovating to make the jobs of attorneys and law firms easier.
  • The Epiq Service cloud provides advanced legal business intelligence, convenient service request modules, spend management dashboards, data transfer tools, and on-demand project status updates.
  • The Epiq Service Cloud also includes several business-of-law applications and services designed to provide general counsel and legal operations professionals with more visibility into department and project-level service, cost, and risk.

NATIONAL VISION HOLDINGS, INC. (NASDAQ: EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against National Vision Holdings, Inc. (NASDAQ: EYE)

Retrieved on: 
Thursday, February 2, 2023
CSS, Lens (anatomy), Optometry, COVID-19, The Legal 500, EPS, Advertising, LLP, Court, Labour government, District court, Investment, Qatar National Vision 2030, Glasses, EYE, News, Security (finance)

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of National Vision Holdings, Inc. (“National Vision” or the “Company”) (NASDAQ: EYE) between May 13, 2021 and May 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of Georgia and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.
  • On May 10, 2022, National Vision issued deeply disappointing financial and operational results for its first fiscal quarter of 2022.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)

Retrieved on: 
Thursday, February 2, 2023
Mab, IC50, COVID-19, The Legal 500, Coronavirus, Press release, Advertising, LLP, Vaccine, Court, Therapy, VOC, Prospectus, Labour government, District court, Severe acute respiratory syndrome coronavirus 2, WHO, Investment, Alpha, Tobacco, Pharmaceutical industry, Animal, Security (finance), Omicron, Adagio

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Adagio” or the “Company”) (NASDAQ: IVVD) between November 29, 2021 and December 14, 2021, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the District of Massachusetts and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the District of Massachusetts and alleges violations of the Securities Exchange Act of 1934.
  • Adagio is a clinical-stage biopharmaceutical company that during the Class Period was focused on developing a monoclonal antibody (“mAb”) therapy for the prevention and treatment of COVID-19.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

ALLIANZ SE (OTC: ALIZY) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Allianz SE (OTC: ALIZY)

Retrieved on: 
Thursday, February 2, 2023
Annual report, Allianz Global Investors, Security (finance), The Legal 500, Advertising, Central District, LLP, Risk, Court, OTC, News, Labour government, SE, District court, AGI, Investment, Ridesharing company, Renewable energy, Allianz

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Allianz SE (“Allianz” or the “Company”) (OTC: ALIZY) between March 9, 2018 and May 17, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Allianz SE Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Allianz SE (“Allianz” or the “Company”) (OTC: ALIZY) between March 9, 2018 and May 17, 2022, inclusive (the “Class Period”).
  • The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

Retrieved on: 
Tuesday, January 31, 2023
Marketing, RTF, Food, Food and Drug Administration, CNS, The Legal 500, Advertising, Cancer, Bias, Court, Therapy, Survival, Advisory Committee, Labour government, Patient, FDA, District court, Investment, Aerospace, Letter, News, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • Y-mAbs is a clinical-stage biopharmaceutical company focused on developing antibody therapeutics and medicines for the treatment of cancer patients of all ages.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.